Kalvista Pharmaceuticals logo

Kalvista Pharmaceuticals share price today

(KALV)

Kalvista Pharmaceuticals share price is $8.86 & ₹759.66 as on 3 Jan 2025, 2.30 'hrs' IST

$8.86

0.39

(4.6%)

Market is closed - opens 8 PM, 03 Jan 2025

View live Kalvista Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Kalvista Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Kalvista Pharmaceuticals. Get details on the Indian mutual funds that are investing in Kalvista Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Kalvista Pharmaceuticals's financials.

Kalvista Pharmaceuticals share price movements

  • Today's Low: $8.57
    Today's High: $9.04

    Day's Volatility :5.2%

  • 52 Weeks Low: $7.97
    52 Weeks High: $16.88

    52 Weeks Volatility :52.78%

Kalvista Pharmaceuticals Returns

PeriodKalvista Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-25.44%
-10.0%
0.0%
6 Months
-28.16%
-4.7%
0.0%
1 Year
-27.79%
-0.9%
0.0%
3 Years
-37.77%
-2.4%
-21.2%

Kalvista Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$8.47
Open
$8.6
Today's High
$9.035
Today's Low
$8.565
Market Capitalization
$418.6M
Today's Volume
$176.2K
52 Week High
$16.88
52 Week Low
$7.97
Revenue TTM
$3.8M
EBITDA
$-154.7M
Earnings Per Share (EPS)
$-3.68
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-90.84%

How to invest in Kalvista Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Kalvista Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Kalvista Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Kalvista Pharmaceuticals or KALV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Kalvista Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Kalvista Pharmaceuticals shares which would translate to 0.097 fractional shares of Kalvista Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Kalvista Pharmaceuticals, in just a few clicks!

Returns in Kalvista Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kalvista Pharmaceuticals investment value today

Current value as on today

₹78,508

Returns

₹21,492

(-21.49%)

Returns from Kalvista Pharmaceuticals Stock

₹24,467 (-24.47%)

Dollar Returns

₹2,975 (+2.97%)

Indian investors sentiment towards Kalvista Pharmaceuticals

200%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Search volume for Kalvista Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Jan 3, 2025. 200% more investors are searching Kalvista Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Kalvista Pharmaceuticals

  • VR Adviser, LLC

    12.70%

  • TANG CAPITAL MANAGEMENT LLC

    8.78%

  • Suvretta Capital Management, LLC

    8.56%

  • Vestal Point Capital LP

    8.13%

  • Capital World Investors

    6.86%

  • BlackRock Inc

    5.98%

Analyst Recommendation on Kalvista Pharmaceuticals

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Kalvista Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Kalvista Pharmaceuticals

What analysts predicted

Upside of 211.19%

Current:

$8.86

Target:

$27.57

Insights on Kalvista Pharmaceuticals

  • Price Movement

    In the last 7 days, KALV stock has moved down by -4.1%
  • KALV vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 20.7% return, outperforming this stock by 51.0%
  • KALV vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 74.8%
  • Price to Sales

    ForKALV every $1 of sales, investors are willing to pay $39.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Kalvista Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Kalvista Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Kalvista Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Kalvista Pharmaceuticals Inc
-12.95%
-28.16%
-27.79%
-37.77%
-50.29%
Regeneron Pharmaceuticals, Inc.
-4.97%
-31.12%
-21.91%
15.48%
91.62%
Biontech Se
-1.42%
42.28%
6.01%
-49.15%
155.61%
Alnylam Pharmaceuticals, Inc.
-6.56%
-6.26%
22.36%
42.41%
102.91%
Vertex Pharmaceuticals Incorporated
-11.88%
-15.14%
-3.23%
81.51%
79.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Kalvista Pharmaceuticals Inc
NA
NA
0.0
-3.65
-0.91
-0.54
NA
4.86
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Kalvista Pharmaceuticals Inc
Buy
$418.6M
-50.29%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
91.62%
17.61
33.61%
Biontech Se
Buy
$27.3B
155.61%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
102.91%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
79.75%
32.84
-4.51%

About Kalvista Pharmaceuticals

kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.
Organization
Kalvista Pharmaceuticals
Employees
150
CEO
Mr. Benjamin L. Palleiko
Industry
Health Technology

Management People of Kalvista Pharmaceuticals

NameTitle
Mr. Benjamin L. Palleiko
CEO & Director
Dr. Christopher M. Yea Ph.D.
Chief Development Officer
Dr. Paul K. Audhya M.B.A., M.D.
Chief Medical Officer
Mr. Brian Piekos
Chief Financial Officer
Mr. Ryan Baker
Head of Investor Relations
Mr. Brian Krex J.D.
General Counsel
Jarrod Aldom
Vice President of Corporate Communications
Ms. Rachel M. Morten
Senior Vice President of Regulatory Affairs & QA
Dr. Michael D. Smith Pharm.D.
Senior Vice President of Development
Ms. Nicole Sweeny
Chief Commercial Officer

Important FAQs about investing in Kalvista Pharmaceuticals from India :

What is Kalvista Pharmaceuticals share price today?

Kalvista Pharmaceuticals share price today stands at $8.86, Open: $8.60 ; Previous Close: $8.47 ; High: $9.04 ; Low: $8.57 ; 52 Week High: $16.88 ; 52 Week Low: $7.97. The stock opens at $8.60, after a previous close of $8.47. The stock reached a daily high of $9.04 and a low of $8.57, with a 52-week high of $16.88 and a 52-week low of $7.97.

Can Indians buy Kalvista Pharmaceuticals shares?

Yes, Indians can invest in the Kalvista Pharmaceuticals (KALV) from India.

With INDmoney, you can buy Kalvista Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Kalvista Pharmaceuticals at zero transaction cost.

How can I buy Kalvista Pharmaceuticals shares from India?

It is very easy to buy Kalvista Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Kalvista Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Kalvista Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Kalvista Pharmaceuticals stocks?

To start investing in Kalvista Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Kalvista Pharmaceuticals

Today’s highest price of Kalvista Pharmaceuticals (KALV) is $9.04.

Today’s lowest price of Kalvista Pharmaceuticals (KALV) is $8.57.

What is today's market capitalisation of Kalvista Pharmaceuticals

Today's market capitalisation of Kalvista Pharmaceuticals KALV is 418.6M

What is the 52 Week High and Low Range of Kalvista Pharmaceuticals

  • 52 Week High

    $16.88

  • 52 Week Low

    $7.97

What are the historical returns of Kalvista Pharmaceuticals?

  • 1 Month Returns

    -12.95%

  • 3 Months Returns

    -28.16%

  • 1 Year Returns

    -27.79%

  • 5 Years Returns

    -50.29%

Who is the Chief Executive Officer (CEO) of Kalvista Pharmaceuticals

Mr. Benjamin L. Palleiko is the current Chief Executive Officer (CEO) of Kalvista Pharmaceuticals.